Skip to content

CVE-2023-51142

Zkteco Biotime information disclosure

7.5 HIGHPublic exploitEPSS 0.73%
  1. Published10 Apr 2024

Description

An issue in ZKTeco BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information.

CVSS 3.1 breakdown

Attack vectorNetwork
Attack complexityLow
Privileges requiredNone
User interactionNone
ScopeUnchanged
ConfidentialityHigh
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Affected products

Zkteco Biotime8.5.4

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

Frequently asked

Is CVE-2023-51142 being actively exploited?

CVE-2023-51142 is not in the CISA KEV catalog. A public exploit reference exists, so treat it as exploitable. Its EPSS exploit probability is 0.73%.

How severe is CVE-2023-51142?

CVE-2023-51142 has a CVSS 3.1 base score of 7.5, rated high. EPSS estimates a 0.73% probability of exploitation.

Which products are affected by CVE-2023-51142?

Affected products include Zkteco Biotime.

How do I fix CVE-2023-51142?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2023-51142 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

Get Patch this first every Monday

Five vulnerabilities that matter this week, ranked on real exploitation. Plain language, one email, no spam.

You can unsubscribe with one click from every issue. We handle your details as described in our privacy policy.

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.